FFCP PHASE2:Hg19::chr10:96363899..96363904,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chr10:96363899..96363904, + |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr10:96363899..96363904, + |
| Coexpression cluster: | C2082_testicular_iPS_retinoblastoma_HES3GFP_H9_rhabdomyosarcoma_teratocarcinoma |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr10:96363899..96363904+ |
|---|
0
10
20
30
40
50
60
70
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| cancer | 9.06e-61 | 235 |
| disease of cellular proliferation | 5.74e-59 | 239 |
| cell type cancer | 1.08e-36 | 143 |
| carcinoma | 6.81e-29 | 106 |
| organ system cancer | 2.95e-25 | 137 |
| hematologic cancer | 2.06e-17 | 51 |
| immune system cancer | 2.06e-17 | 51 |
| leukemia | 4.09e-13 | 39 |
| myeloid leukemia | 5.21e-09 | 31 |
| germ cell and embryonal cancer | 7.71e-09 | 22 |
Showing 1 to 10 of 13 entries
